Federated Hermes
PSTX

Federated Hermes’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Federated Hermes’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,656
Closed -$167K – 2334
2021
Q2 		$167K Buy
+16,656
New +$149K ﹤0.01% 1705

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes's PSTX Position: Q3 2021 in Review

Federated Hermes sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q3 2021, closing a stake of 16,656 shares — an estimated $167K sold.

Federated Hermes first reported a position in PSTX in Q2 2021 and held it in 1 quarter. The position peaked at $167K in Q2 2021. 65 funds tracked by Wall St. Rank hold PSTX as of Q3 2021.

  • Federated Hermes reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Federated Hermes sold 16,656 Poseida Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $167K.
  • Federated Hermes first reported a position in Poseida Therapeutics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Federated Hermes's Poseida Therapeutics, Inc. Common Stock position peaked at $167K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.